May 2026

27 year old active female with pain in the elbow since 2 years.

She was treated as golfer’s elbow for 6 months, without relief.

Radiographs

  • Well defined, lytic, expansile lesion in the meta epiphysis region of humerus and ulna
  • The lesion in the ulna extends up to the subarticular region, the humeral lesion spares the subarticular zone
  • Narrow zone of transition
  • Sclerotic margins
  • Overlying cortical thinning (arrows) but no frank breach
  • No matrix mineralization
  • No ground glassing
  • No periosteal reaction No periarticular soft tissue density

Differentials on radiographs

  • Multicentric giant cell tumor
  • Fibrous dysplasia
  • Low grade chondrosarcoma

MRI

T1

PD

T2

T1 post contrast

MRI features:  Well defined soft tissue, T1 / T2 low signal, areas of cortical breach in distal humerus anteriorly, No blooming on GRE, no perilesonal bone marrow edema, no fluid fluid levels homogeneous post contrast enhancment

MRI differentials narrowed down to:

  • Multicentric giant cell tumor
  • Fibrous dysplasia

Biopsy was performed because management depended upon diagnosis.

 GCT → complete tumor eradication (intralesional curettage + bone cement/ graft or en-bloc resection), denosumab therapy

 FD →  More conservative approach, follow up, bisphosphonate therapy, cortical bone graft and internal fixation (to prevent pathological fracture).

Biopsy from the left distal humerus and proximal ulna confirms a fibro-osseous lesion consistent with fibrous dysplasia (FD).

Key pathology features:

  • Irregular curvilinear trabeculae of woven bone in a fibrous stroma.
  • Classic “Chinese character” trabecular pattern.
  • No significant osteoblastic rimming.
  • No cytologic atypia, mitosis, necrosis, or malignant transformation.
  • IHC for  H3F3A(H3.3 G34W – molecular mutation seen in 95% of GCT) → NEGATIVE

Involvement of multiple adjacent bones within a single limb segment (distal humerus + proximal ulna) favors: Polyostotic monomelic fibrous dysplasia (polyostotic FD confined to one extremity).

Features

FeatureGiant Cell Tumor Clear Cell ChondrosarcomaFibrous Dysplasia
AgeSkeletally mature (20–40 yrs)Adults (20–50 yrs)Younger patients
LocationEccentric epiphyseal/meta-epiphyseal reaching subarticular boneEpiphyseal/meta-epiphysealUsually metaphyseal/diaphyseal
MarginWell-defined, narrow transition zoneWell-defined, may have sclerotic rimWell-defined with thick “rind” sclerosis
MatrixUsually no matrix mineralizationChondroid calcification  (rings/arcs)Ground-glass matrix
ExpansionExpansile remodeling commonMild-moderate expansionSmooth bony expansion
CortexCortical thinning ± breachCortical thinning/destruction possibleCortical thinning with maintained contour
Soft tissue massMay occur in aggressive lesionsCan occurRare
Key clue“Soap-bubble” expansile subarticular lytic lesion without sclerosisEpiphyseal lesion with chondroid calcificationsGround-glass expansile lesion with rind sclerosis

Key Points

Multicentric Giant Cell Tumor of Bone:

  • Extremely rare →  occurs in less than 1% of all GCTB cases. Finding multiple GCT lesions is an exceptional clinical finding.
  • While regular GCT affects adults aged 20–40, the multicentric variant targets a significantly younger population (often teenagers and adults around 20 years old) and shows a pronounced female predominance.
  • H3F3A(H3.3 G34W – molecular mutation seen in 95% of GCT

Polyostotic FD

  • The McCune-Albright Syndrome: Classic clinical triad known as McCune-Albright Syndrome.
    • Polyostotic FD
    • Café-au-lait skin pigmentation
    • Hyperfunctioning Endocrinopathies
  • Unilateral Predilection: confine themselves to just one side of the body.
  • Somatic Mosaicism: post-zygotic, activating mutations in the GNAS gene.

Comments are closed.